Do you have an interest in safe medicines for children – as a parent, researcher or prescriber? If so, you are invited to participate in a stakeholder consultation launched by the European Commission. The aim is to gather real-life experiences and opinions on the Paediatric Regulation which came into force a decade ago and has three main objectives:

  • to ensure high-quality research into the development of medicines for children
  • to ensure that the majority of medicines used by children are specifically authorised for such use and so reduce the level of off-label use
  • to ensure the availability of high-quality information about medicines used by children.

The consultation is open until 20 February 2017.

More information about medicines for children and to contribute to the consultation on the website.